KALA BIO, INC. Cash
KALA BIO, INC. (KALA) had Cash of $196.46 million as of 2020-03-31, per its 10-Q filed 2020-05-07.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:Cash · last filed 2020-05-07
- 2020-03-31: Cash $196.46M.
- 2019-12-31: Cash $85.45M.
- 2019-09-30: Cash $97.56M.
- 2019-06-30: Cash $118.01M.
| Period end | Cash |
|---|---|
| 2020-03-31 | $196.46M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $85.45M 10-Q · filed 2020-05-07 |
| 2019-09-30 | $97.56M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $118.01M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $138.94M 10-Q · filed 2020-05-07 |
| 2018-12-31 | $170.90M 10-K · filed 2020-02-12 |
| 2018-09-30 | $74.91M 10-Q · filed 2019-11-07 |
| 2018-06-30 | $91.20M 10-Q · filed 2019-08-06 |
| 2018-03-31 | $100.53M 10-Q · filed 2019-05-09 |
| 2017-12-31 | $114.56M 10-K · filed 2019-03-12 |
| 2017-09-30 | $122.05M 10-Q · filed 2018-11-08 |
| 2017-06-30 | $26.35M 10-Q · filed 2018-08-09 |
| 2017-03-31 | $36.02M 10-Q · filed 2018-05-10 |
| 2016-12-31 | $45.47M 10-K · filed 2018-04-02 |
| 2015-12-31 | $5.76M 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |